Sirolimus- versus paclitaxel-eluting stents for coronary bifurcations intervention
- 1 November 2011
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 80 (4) , 507-513
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Long‐term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug‐eluting and bare‐metal stents: An observational meta‐analysisCatheterization and Cardiovascular Interventions, 2011
- Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary BifurcationsJACC, 2010
- Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation LesionsAngiology, 2008
- A Meta-Analysis of 16 Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in Patients With Coronary Artery DiseaseJACC, 2007
- Drug-eluting stents for the treatment of bifurcation lesions: A randomized comparison between paclitaxel and sirolimus stentsAmerican Heart Journal, 2007
- Pathology of Drug-Eluting Stents in HumansJACC, 2006
- Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting StentsJACC, 2006
- Thrombosis Modulates Arterial Drug Distribution for Drug-Eluting StentsCirculation, 2005
- TAXUS ICirculation, 2003
- A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary RevascularizationNew England Journal of Medicine, 2002